A couple of stocks that have been hot buys this year are Regeneron Pharmaceuticals (NASDAQ: REGN) and T-Mobile US (NASDAQ: TMUS). These businesses defied the bear market as their strong fundamentals and continued growth gave investors reason to rally around their stocks. Unlike the S&P 500, which is down about 17% this year, these two stocks have generated positive returns of 15% or more.

But there are metrics to suggest these two stocks have more growth to come. Here's a closer look at why both of these stocks can still soar higher in 2023.

Biotech company Regeneron focuses on creating "life-transforming medicines," and that can be good for the bottom line as well as for patients. Its business centers around its eyecare medication, Eylea (aflibercept), which today generates the bulk of Regeneron's revenue.

Continue reading

Source Fool.com